Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.

Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.

<h4>Introduction</h4>Interim PET (iPET) assessment is important for response adaptation in Hodgkin lymphoma (HL). The current standard for iPET assessment is the Deauville score (DS). The aim of our study was to evaluate the causes of interobserver variability in assigning the DS for iPE...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Thomas W Georgi, Lars Kurch, Dirk Hasenclever, Victoria S Warbey, Lucy Pike, John Radford, Osama Sabri, Regine Kluge, Sally F Barrington
Формат:	Өгүүллэг
Хэл сонгох:	English
Хэвлэсэн:	Public Library of Science (PLoS) 2023-01-01
Цуврал:	PLoS ONE
Онлайн хандалт:	https://doi.org/10.1371/journal.pone.0283694

Ижил төстэй зүйлс

Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial.
-н: Thomas W Georgi, зэрэг
Хэвлэсэн: (2020-01-01)

Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma
-н: Lars Kurch, зэрэг
Хэвлэсэн: (2021-09-01)

Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
-н: Regine Kluge, зэрэг
Хэвлэсэн: (2016-01-01)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
-н: M. André, зэрэг
Хэвлэсэн: (2011-01-01)

Automatic classification of lymphoma lesions in FDG-PET–Differentiation between tumor and non-tumor uptake
-н: Thomas W Georgi, зэрэг
Хэвлэсэн: (2022-01-01)

Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake.
-н: Thomas W Georgi, зэрэг
Хэвлэсэн: (2022-01-01)

End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
-н: Karan L. Chohan, зэрэг
Хэвлэсэн: (2022-12-01)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
-н: Akram Al-Ibraheem, зэрэг
Хэвлэсэн: (2022-10-01)

Interim PET for prognosis in adults with Hodgkin lymphoma: A prognostic factor exemplar review
-н: Skoetz, N, зэрэг
Хэвлэсэн: (2017)

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
-н: Diego Villa, зэрэг
Хэвлэсэн: (2018-12-01)

Prevention of activated brown adipose tissue on 18F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trial
-н: C. Pötzsch, зэрэг
Хэвлэсэн: (2023-12-01)

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment
-н: Elizabeth Katherine Anna Triumbari, зэрэг
Хэвлэсэн: (2022-09-01)

Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation
-н: L. Kurch, зэрэг
Хэвлэсэн: (2021-07-01)

Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease
-н: Tseng Diane, зэрэг
Хэвлэсэн: (2012-01-01)

Hodgkin lymphoma: hypodense lesions in mediastinal masses
-н: Adrian Damek, зэрэг
Хэвлэсэн: (2024-06-01)

Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies
-н: Aldin, A, зэрэг
Хэвлэсэн: (2019)

Interim PET‐results for prognosis in adults with Hodgkin lymphoma: A systematic review and meta‐analysis of prognostic factor studies
-н: Aldin, A, зэрэг
Хэвлэсэн: (2020)

P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
-н: Chiara Rusconi, зэрэг
Хэвлэсэн: (2022-10-01)

S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA
-н: M. C. Pirosa, зэрэг
Хэвлэсэн: (2022-06-01)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
-н: Arun Seshachalam, зэрэг
Хэвлэсэн: (2019-12-01)

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
Хэвлэсэн: (2018-10-01)

P1070: DECISIONAL ROLE OF INTERIM PET IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH BEGEV CHEMOTHERAPY AS FIRST SALVAGE
-н: Chiara Rusconi, зэрэг
Хэвлэсэн: (2023-08-01)

FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
-н: Josée M. Zijlstra, зэрэг
Хэвлэсэн: (2016-11-01)

Interim results of a UK NCRI randomised trial comparing involved field radiotherapy with no further treatment after 3 cycles ABVD and a negative PET scan in clinical stages IA/IIA Hodgkin lymphoma
-н: Radford, J, зэрэг
Хэвлэсэн: (2007)

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma
-н: Tim M. Illidge, зэрэг
Хэвлэсэн: (2020-01-01)

P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
-н: Eleonora Calabretta, зэрэг
Хэвлэсэн: (2022-10-01)

P026 (0057) INTERIM- PET RESULTS FOR PROGNOSIS IN ADULTS WITH HODGKIN LYMPHOMA: A PROGNOSTIC FACTOR EXEMPLAR REVIEW (PRELIMINARY RESULTS)
Хэвлэсэн: (2018-10-01)

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials
-н: Simonetta Viviani, зэрэг
Хэвлэсэн: (2022-10-01)

Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report
-н: Lars Kurch, зэрэг
Хэвлэсэн: (2022-01-01)

The role of FDG-PET in Hodgkin lymphoma
-н: Edyta Subocz, зэрэг
Хэвлэсэн: (2017-06-01)

Healthy tissue metabolism assessed by [18F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients
-н: Afnan A. Malaih, зэрэг
Хэвлэсэн: (2024-06-01)

The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria
-н: Elske Quak, зэрэг
Хэвлэсэн: (2014-06-01)

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
-н: Andrea Gallamini, зэрэг
Хэвлэсэн: (2014-06-01)

The utility of PET/CT with 18F-FDG in the study of Hodgkin's lymphoma and non-Hodgkin's lymphoma
-н: Marta Milhões, зэрэг
Хэвлэсэн: (2015-11-01)

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
-н: Stephen Daw, зэрэг
Хэвлэсэн: (2020-02-01)

T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies
-н: Dennis A. Eichenauer, зэрэг
Хэвлэсэн: (2022-10-01)

Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group
-н: Aznar, M, зэрэг
Хэвлэсэн: (2017)

MRI versus CT and PET/CT in the Preoperative Assessment of Hodgkin and Non-Hodgkin Lymphomas
-н: Francesca Maccioni, зэрэг
Хэвлэсэн: (2021-10-01)

Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma
-н: Özgür Ömür, зэрэг
Хэвлэсэн: (2014-03-01)

Machine Learning to Predict Interim Response in Pediatric Classical Hodgkin Lymphoma Using Affordable Blood Tests
-н: Jennifer A. Geel, зэрэг
Хэвлэсэн: (2024-10-01)